Interactions of nonsteroidal anti-inflammatory drugs with rat renal organic anion transporter, OAT-K1

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1039-1042

  Masuda, Satohiro ^a   Saito, Hideyuki ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUFENAMIC ACID; INDOMETACIN; KETOPROFEN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANION TRANSPORT; ARTICLE; BASOLATERAL MEMBRANE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; GLOMERULUS FILTRATION RATE; KIDNEY TUBULE ABSORPTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

ANIMALS; ANION TRANSPORT PROTEINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRIER PROTEINS; DRUG INTERACTIONS; INDOMETHACIN; KETOPROFEN; KIDNEY; MALE; METHOTREXATE; RATS; RATS, WISTAR; TETRAETHYLAMMONIUM COMPOUNDS;

EID: 0031459990     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. BANNWARTH, B., PÉHOURCQ, F., SCHAEVERBEKE, T. AND DEHAIS, J.: Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin. Pharmacokinet. 30: 194-210, 1996.
2. BOURKE, R. S., CHHEDA, G., BREMER, A., WATANABE, O. AND TOWER, D. B.: Inhibition of renal tubular transport of methotrexate by probenecid. Cancer Res. 35: 110-116, 1975.
3. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
4. BROUWERS, J. R. B. J. AND DE SMET, P. A. G. M.: Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs. Clin. Pharmacokinet. 27: 462-485, 1994.
5. DIXON, M.: The determination of enzyme inhibitor constants. Biochem. J. 55: 170-171, 1953.
6. FREI, E., JAFFE, N., TATTERSHALL, M. H. N., PITMAN, S. AND PARKER, L.: New approaches to cancer chemotherapy with methotrexate. N. Engl. J. Med. 292: 846-851, 1975.
7. FRENIA, M. L. AND LONG, K. S.: Methotrexate and nonsteroidal antiinflammatory drug interactions. Ann. Pharmacother. 26: 234-237, 1992.
8. +/bile acid cotransport system. Proc. Natl. Acad. Sci. U.S.A. 88: 10629-10633, 1991.
9. HE, Y., TANIGAWARA, Y., YASUHARA, M. AND HORI, R.: Effect of folinic acid on tissue residence and excretion of methotrexate in rats. Drug Metab. Dispos. 19: 729-734, 1991.
10. JACKSON, R. C.: Biological effects of folic acid antagonists with antineoplastic activity. Pharmacol. Ther. 25: 61-82, 1984.
11. +-independent organic anion transporter. Proc. Natl. Acad. Sci. U.S.A. 91; 133-137, 1994.
12. KREMER, J. M. AND HAMILTON, R. A.: The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg. J. Rheumatol 22: 2072-2077, 1995.
13. MEIER, P. J.: Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am. J. Physiol. 269: G801-G812, 1995.
14. NIERENBERG, D. W.: Competitive inhibition of methotrexate accumulation in rabbit kidney slices by nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 226: 1-6, 1983.
15. PAULUSMA, C. C., BOSMA, P. J., ZAMAN, G. J. R., BAKKER, C. T. M., OTTER, M., SCHEFFER, G. L., SCHEPER, R. J., BORST, P. AND OUDE ELFERINK, R. P. J.: Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271: 1126-1128, 1996.
16. SAITO, H., MASUDA, S. AND INUI, K.: Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney. J. Biol. Chem. 271: 20719-20725, 1996.
17. 1. Am. J. Physiol. 262: C59-C66, 1992.
18. SHEN, D. D. AND AZARNOFF, D. L.: Clinical pharmacokinetics of methotrexate. Clin. Pharmacokinet. 3: 1-13, 1978.
19. STATKEVICH, P., FOURNIER, D. J. AND SWEENEY, K. R.: Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 265: 1118-1124, 1993.
20. THYSS, A., MILANO, G., KUBAR, J. AND NAMER, M.: Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet 1: 256-258, 1986.
21. TRACY, T. S., KROHN, K., BRADLEY, J. D., HALL, S. D. AND BRATER, D. C.: The effect of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis. Eur. J. Clin. Pharmacol. 42: 121-125, 1992.